Clinical Trial: A single-center, open-label, single-arm phase II clinical study to evaluate the diagnostic performance, imaging feasibility, and safety of NC527-X for injection during breast cancer surgery (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-center, open-label, single-arm phase II clinical study to evaluate the diagnostic performance, imaging feasibility, and safety of NC527-X for injection during breast cancer surgery'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129489

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Harbin Medical University Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330998

Published by HT Digital Content Services with permission from Health Daily Digest....